
By Michael Erman
NEW YORK (Reuters) -The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the agency's top officials said on Wednesday.
FDA Commissioner Marty Makary and Chief Medical and Scientific Officer Vinay Prasad said in an essay published in the New England Journal of Medicine that for certain conditions, companies could rely on appropriately designed studies with small sample sizes rather than randomized trials. They will rely on biological plausibility and clinical improvements in those early patients.
"Current regulations are onerous and unnecessarily demanding," Makary and Prasad wrote. "For patients and families, there is no time to wait."
The new "plausible-mechanism" pathway would allow the agency to grant marketing authorization after manufacturers demonstrate success with several consecutive patients.
Companies that receive these approvals will be required to collect real-world evidence to confirm efficacy continues and to look for safety issues that might arise.
The new approach will prioritize treatments for rare diseases that are fatal or cause severe childhood disability. Common diseases with unmet medical needs may also qualify.
While makers of cell and gene therapies are likely to be significant beneficiaries of the new approval process, Makary and Prasad said that other types of treatments could also receive licensure this way.
"The FDA will work as a partner and guide in ushering these therapies to market," the officials wrote.
(Reporting by Michael ErmanEditing by Bill Berkrot)
LATEST POSTS
- 1
One-third of asylum applications by Iranians approved in Germany - 2
Merz: 80% of Syrians in Germany should return in three years - 3
Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect - 4
Russian strikes on Ukraine kill 5 people and wound 30 more - 5
Vote in favor of your Number one method for commending a birthday
Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond
Asia's migrant workers debate if Gulf jobs are worth deadly risk of Iran war
Figure out How to Get the Best Open Record Rewards
Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
Flu illness count nears 5 million, with New York City among the hardest hit
Venezuelan President Maduro arrives in New York following U.S. capture: Full coverage
From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
Which Diet Prompts the Incomparable Wellbeing Results?












